Sign in
4

Changes in Ownership

Merck & Co., Inc. Filed Acc 0001127602-22-025018

Executive Chair sold 470,000 shares at an average $98.66 ($46,372,118)

  • Executive Chair acquired 470,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

FRAZIER KENNETH C · Executive Chair

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2022-11-03 Exercise or conversion : show line 1 in the form +235,000 935,653.06 D
2022-11-03 Sale : show line 2 in the form −214,617 $98.68 $21,178,084 721,036.06 D
2022-11-03 Sale : show line 3 in the form −20,383 $99.09 $2,019,804 700,653.06 D
2022-11-04 Exercise or conversion : show line 4 in the form +235,000 935,653.06 D
2022-11-04 Sale : show line 5 in the form −200,190 $98.53 $19,725,241 735,463.06 D
2022-11-04 Sale : show line 6 in the form −34,810 $99.08 $3,448,989 700,653.06 D
Open-market sales · 470,000 sh · avg $98.66 · $46,372,118

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-11-03 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −235,000 470,769 D
2022-11-04 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −235,000 235,769 D
Loading xslF345X03/form4.xml…